
Clot-busting drug could harm stroke treatment response
A clot-busting drug may stop promising stroke medicine from working properly, research reveals. Researchers at the University of Manchester found the clot-busting therapy, known as tissue plasminogen activator (tPA), interacts negatively with the anti-inflammatory treatment anakinra, highlighting the need for new stroke therapies alongside existing standard care. Read More





